Elizabeth Skelly

New approach methodologies in nanomedicine: bridging the gap between in silico, in vitro, and in vivo systems

The rise of nanomedicine has led to the regulatory approval of more than 80 nanoparticle (NP)-based therapeutics over the past two decades. Further advancement in the field requires a deeper understanding of the nano-bio interface of NPs, including their uptake, delivery, efficacy, toxicity, and adverse effects. Despit...